Cargando…
European active surveillance study of women taking HRT (EURAS-HRT): study protocol [NCT00214903]
BACKGROUND: The post marketing safety surveillance program for a drug containing a new chemical entity should assess both, the safety outcomes that relate specifically to the targeted population, as well as those that could potentially be related to special pharmacological characteristics of the dru...
| Autores principales: | , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2006
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1351171/ https://www.ncbi.nlm.nih.gov/pubmed/16417621 http://dx.doi.org/10.1186/1472-6874-6-1 |